4min chapter

The Intelligence from The Economist cover image

Hot shot: the wider promise of weight-loss jabs

The Intelligence from The Economist

CHAPTER

The Promise of GLP-1 Receptor Agonists

This chapter explores the transformative effects of GLP-1 receptor agonists, new weight-loss drugs initially developed for diabetes that may also improve heart health and other conditions. It highlights the ongoing research and broader potential applications of these medications, likening them to a 'Swiss army knife' for various health issues.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode